Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study. (Q38061501)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study. |
scientific article |
Statements
Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study (English)
Jerónimo Saíz
Amalia Lafuente
1 November 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference